Pediatrix Medical Group, Inc. (NYSE:MD) Shares Bought by SummerHaven Investment Management LLC

SummerHaven Investment Management LLC lifted its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 3.8% in the 2nd quarter, HoldingsChannel reports. The firm owned 55,951 shares of the company’s stock after purchasing an additional 2,069 shares during the quarter. SummerHaven Investment Management LLC’s holdings in Pediatrix Medical Group were worth $422,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of MD. Performa Ltd US LLC raised its holdings in Pediatrix Medical Group by 130.8% during the fourth quarter. Performa Ltd US LLC now owns 3,000 shares of the company’s stock worth $28,000 after purchasing an additional 1,700 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of Pediatrix Medical Group by 47.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock valued at $36,000 after purchasing an additional 1,524 shares during the period. Counterpoint Mutual Funds LLC raised its stake in shares of Pediatrix Medical Group by 53.4% in the 4th quarter. Counterpoint Mutual Funds LLC now owns 10,140 shares of the company’s stock worth $94,000 after buying an additional 3,528 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Pediatrix Medical Group in the first quarter valued at $124,000. Finally, Jump Financial LLC bought a new position in Pediatrix Medical Group during the fourth quarter valued at about $154,000. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD traded up $0.18 on Friday, hitting $11.20. 97,377 shares of the company were exchanged, compared to its average volume of 939,857. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.38 and a current ratio of 1.38. The company’s 50 day moving average price is $8.26 and its two-hundred day moving average price is $8.55. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $14.68. The firm has a market capitalization of $961.74 million, a price-to-earnings ratio of -12.96, a PEG ratio of 1.63 and a beta of 1.56.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.03. The firm had revenue of $504.30 million for the quarter, compared to analyst estimates of $505.49 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The business’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.37 EPS. Research analysts expect that Pediatrix Medical Group, Inc. will post 1.18 earnings per share for the current year.

Insider Activity at Pediatrix Medical Group

In related news, CFO C Marc Richards sold 17,438 shares of Pediatrix Medical Group stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $10.08, for a total value of $175,775.04. Following the completion of the transaction, the chief financial officer now directly owns 175,347 shares of the company’s stock, valued at $1,767,497.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on MD. Truist Financial upped their price target on shares of Pediatrix Medical Group from $8.00 to $10.00 and gave the company a “hold” rating in a report on Thursday, August 15th. UBS Group lifted their target price on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a report on Friday, August 9th. Deutsche Bank Aktiengesellschaft raised Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 target price for the company in a report on Friday, June 7th. Finally, StockNews.com raised Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research note on Wednesday, August 7th. Six equities research analysts have rated the stock with a hold rating, According to data from MarketBeat, Pediatrix Medical Group has an average rating of “Hold” and a consensus price target of $9.30.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.